Publicacions en què col·labora amb Alejandro Fernández Montero (18)

2023

  1. Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset

    European Journal of Clinical Investigation, Vol. 53, Núm. 10

  2. Photodynamic nasal SARS-CoV-2 decolonization shortens infectivity and influences specific T-Cell responses

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  3. Repercussions of absolute and time-rated BMI “yo-yo” fluctuations on cardiovascular stress-related morbidities within the vascular-metabolic CUN cohort

    Frontiers in Endocrinology, Vol. 13

2022

  1. Interactive Role of Surrogate Liver Fibrosis Assessment and Insulin Resistance on the Incidence of Major Cardiovascular Events

    Journal of Clinical Medicine, Vol. 11, Núm. 17

2021

  1. A Mediterranean lifestyle reduces the risk of cardiovascular disease in the “Seguimiento Universidad de Navarra” (SUN) cohort

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 6, pp. 1728-1737

  2. Association of sdf1 and mmp12 with atherosclerosis and inflammation: Clinical and experimental study

    Life, Vol. 11, Núm. 5

  3. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

    EClinicalMedicine, Vol. 32

  4. Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values

    eClinicalMedicine, Vol. 37

2019

  1. Analysis of monocitary subpopulations in relation to cardiovascular risk factors

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  2. Análisis de subpoblaciones monocitarias en relación con los factores de riesgo cardiovascular

    Clínica e investigación en arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

2017

  1. Clinical Features of Smokers With Radiological Emphysema But Without Airway Limitation

    Chest, Vol. 151, Núm. 2, pp. 358-365

  2. Risk of incident ischemic stroke according to the metabolic health and obesity states in the Vascular-Metabolic CUN cohort

    International Journal of Stroke, Vol. 12, Núm. 2, pp. 187-191

2016

  1. Are all metabolically healthy individuals with obesity at the same risk of diabetes onset?

    Obesity, Vol. 24, Núm. 12, pp. 2615-2623

  2. Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort

    Journal of Hypertension, Vol. 34, Núm. 7, pp. 1257-1265

  3. The TyG index may predict the development of cardiovascular events

    European Journal of Clinical Investigation, Vol. 46, Núm. 2, pp. 189-197

  4. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The Vascular-Metabolic CUN cohort

    Preventive Medicine, Vol. 86, pp. 99-105

  5. TyG index change is more determinant for forecasting type 2 diabetes onset than weight gain

    Medicine (United States), Vol. 95, Núm. 19

  6. Uso del QuantiFERON-TB Gold en la consulta de Medicina del Trabajo en un medio hospitalario. 8 años de experiencia

    Revista de la Asociacion Espanola de Especialistas en Medicina del Trabajo, Vol. 25, Núm. 2, pp. 58-72